Hisamitsu Pharmaceutical Overview

  • Status
  • Public
  • Employees
  • 3,473
  • Stock Symbol
  • 4530
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $56.97
  • (As of Friday Closing)

Hisamitsu Pharmaceutical General Information


Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 408 Tashiro Daikan-machi
  • Tosu
  • Saga, 841-0017
  • Japan
+81 0000-00-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hisamitsu Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$56.97 $56.17 $43.76 - $70.55 $4.65B 81.7M 114K $1.03

Hisamitsu Pharmaceutical Financials Summary

In Thousands,
TTM 30-Nov-2020 FY 2020 29-Feb-2020 FY 2019 28-Feb-2019 FY 2018 28-Feb-2018
EV 3,509,694 1,914,592 3,032,209 4,930,147
Revenue 1,144,494 1,293,214 1,298,534 1,332,270
EBITDA 268,591 277,385 298,264
Net Income 83,886 171,466 173,889 171,566
Total Assets 2,849,012 2,843,673 2,667,635 2,790,690
Total Debt 14,315 16,420 17,046 19,150
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hisamitsu Pharmaceutical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hisamitsu Pharmaceutical Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 27-Aug-2009 000000000000000000 00000 Pharmaceuticals
To view Hisamitsu Pharmaceutical’s complete acquisitions history, request access »

Hisamitsu Pharmaceutical Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Pharmaceuticals Miami, FL 0000
To view Hisamitsu Pharmaceutical’s complete subsidiaries history, request access »